Credit Suisse Ag Collegium Pharmaceutical, Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Credit Suisse Ag holds 51,278 shares of COLL stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,278

Previous 49,868 2.83%

Holding current value

$1.64 Million

Previous $1.53 Million 29.73%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$31.23 - $40.91 $44,034 - $57,683	1,410 Added 2.83%	51,278 $1.99 Million
Q4 2023 Feb 08, 2024	BUY	$21.16 - $30.8 $37,834 - $55,070	1,788 Added 3.72%	49,868 $1.53 Million
Q3 2023 Nov 13, 2023	BUY	$21.23 - $24.28 $153,959 - $176,078	7,252 Added 17.76%	48,080 $1.07 Million
Q2 2023 Aug 11, 2023	BUY	$21.06 - $24.0 $27,567 - $31,416	1,309 Added 3.31%	40,828 $877,000
Q1 2023 May 10, 2023	BUY	$23.0 - $29.88 $69,644 - $90,476	3,028 Added 8.3%	39,519 $948,000

Q4 2022 Feb 13, 2023	BUY	$16.14 - $23.55 $177,491 - $258,979	10,997 Added 43.14%	36,491 $846,000
Q3 2022 Nov 10, 2022	BUY	$15.46 - $20.1 $3,045 - $3,959	197 Added 0.78%	25,494 $408,000
Q2 2022 Aug 12, 2022	BUY	$14.22 - $20.88 $170 - $250	12 Added 0.05%	25,297 $448,000
Q1 2022 May 16, 2022	BUY	$17.2 - $22.5 $28,741 - $37,597	1,671 Added 7.08%	25,285 $515,000
Q4 2021 Feb 14, 2022	BUY	$17.5 - $21.35 $27,720 - $33,818	1,584 Added 7.19%	23,614 $441,000
Q3 2021 Nov 12, 2021	SELL	$17.75 - $25.39 $92,282 - $132,002	-5,199 Reduced 19.09%	22,030 $435,000
Q2 2021 Aug 16, 2021	BUY	$21.74 - $25.28 $3,739 - $4,348	172 Added 0.64%	27,229 $644,000
Q1 2021 May 14, 2021	SELL	$19.25 - $26.1 $199,949 - $271,100	-10,387 Reduced 27.74%	27,057 $641,000
Q4 2020 Feb 12, 2021	BUY	$17.83 - $22.29 $227,457 - $284,353	12,757 Added 51.67%	37,444 $751,000
Q3 2020 Nov 13, 2020	BUY	$15.78 - $20.82 $33,264 - $43,888	2,108 Added 9.34%	24,687 $513,000
Q2 2020 Aug 12, 2020	SELL	$15.49 - $23.51 $84,900 - $128,858	-5,481 Reduced 19.53%	22,579 $395,000
Q1 2020 May 13, 2020	SELL	$13.89 - $25.45 $192,251 - $352,253	-13,841 Reduced 33.03%	28,060 $458,000
Q4 2019 Feb 12, 2020	BUY	$10.7 - $22.24 $158,862 - $330,197	14,847 Added 54.88%	41,901 $863,000
Q3 2019 Nov 12, 2019	SELL	$10.16 - $13.28 $286,938 - $375,053	-28,242 Reduced 51.07%	27,054 $311,000
Q2 2019 Aug 14, 2019	BUY	$10.62 - $16.59 $294,503 - $460,057	27,731 Added 100.6%	55,296 $727,000
Q1 2019 May 14, 2019	BUY	$13.58 - $18.72 $22,162 - $30,551	1,632 Added 6.29%	27,565 $418,000
Q4 2018 Feb 13, 2019	BUY	$14.78 - $19.68 $74,328 - $98,970	5,029 Added 24.06%	25,933 $445,000
Q3 2018 Nov 13, 2018	SELL	$14.16 - $24.3 $121,209 - $208,008	-8,560 Reduced 29.05%	20,904 $308,000
Q2 2018 Aug 14, 2018	SELL	$21.79 - $28.29 $1.02 Million - $1.32 Million	-46,620 Reduced 61.27%	29,464 $703,000
Q1 2018 May 15, 2018	BUY	$18.15 - $29.21 $853,049 - $1.37 Million	47,000 Added 161.6%	76,084 $1.94 Million
Q4 2017 Feb 14, 2018	BUY	$9.3 - $19.14 $99,063 - $203,879	10,652 Added 57.79%	29,084 $536,000
Q3 2017 Nov 14, 2017	BUY	$9.15 - $11.97 $168,652 - $220,631	18,432	18,432 $193,000

Others Institutions Holding COLL

# of Institutions

231

Shares Held

39.5M

Call Options Held

104K

Put Options Held

15.4K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.09B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account